Best Nanotechnology Companies in Netherlands
The 49 best Nanotechnology companies in Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Nearfield Instruments.
- Nanotechnology Market to Expand at a CAGR of 10.36% by 2027
- Report Forecasts Strong Growth in Nanotechnology Market
- Nanotechnology Market Forecast Unprecedented CAGR of 14.5% During 2022
Our analysis of 50 Nanotechnology companies
$6.5b in tracked funding; 78% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Nanotechnology companies in Netherlands
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Nearfield Instruments Developer of electron microscopes for 3D metrology 67Funding top 26%Tech top 26%Growth top 35%Moat top 39% All 8 signals ▾Fundingtop 26% Techtop 26% Growthtop 35% Moattop 39% Markettop 46% Talentbottom 49% Globalbottom 39% Newsbottom 18% Funding: Raised $169M across 2 rounds · 2 rounds over 9 yrs (0.2/yr) Tech: 43 technologies across 6/8 capability areas · Cloud: Amazon Web Services rank vs industry peers · Fliar Intelligence Index 67/100 | $169M | 24 mo ago | 152 | 2016 | Hamed Sadeghian CEO | WordPressPleskMySQL+24 | — | 1 expansion |
| 2 | VSParticle Provider of nanopowder manufacturing services 40Funding top 32%Product top 36%Innovation top 39%Tech top 49% All 8 signals ▾Fundingtop 32% Producttop 36% Innovationtop 39% Techtop 49% Globalbottom 38% Moatbottom 38% Marketbottom 34% Newsbottom 18% Funding: Raised $26.8M across 8 rounds · 8 rounds over 7 yrs (1.1/yr) Product: 11 distinct product lines · Company stage: Series A rank vs industry peers · Fliar Intelligence Index 40/100 | $27M | 24 mo ago | 26 | 2014 | — | TYPO3 CMSPHPYouTube+10 | — | 1 partnership |
| 3 | Cristal Therapeutics Provides nanomedicines based ON CriPec platform for cancer and inflammation disorder | $21M | 70 mo ago | 6 | 2011 | Cristianne Rijcken Founder and CSO | — | — | 1 launch |
| 4 | Powall Provider of sustainable powders for batteries | $12M | 26 mo ago | 24 | 2014 | Roderik Colen CEO | — | — | — |
| 5 | Amarna Therapeutics Developer of immune-modulating gene therapies for rare and prevalent autoimmune diseases and genetic diseases | $11M | 81 mo ago | 30 | 2008 | Marjanne Messie CFO | CMS Made SimplePleskPHP+15 | 5 patents Patents concentrated in chemistry & materials | — |
| 6 | CarbonX Manufacturer of nanosized carbon structures 40Patents top 23%Innovation top 27%Moat top 28%Funding top 43% All 8 signals ▾Patentstop 23% Innovationtop 27% Moattop 28% Fundingtop 43% Talentbottom 49% Techbottom 44% Globalbottom 35% Marketbottom 32% Patents: 156 patents matched (strict assignee match) · 89 filings since 2022 vs 60 in 2017-21 Innovation: 156 patents (top 12% of patent-holders) · 89 filings since 2022 vs 60 in 2017-21 rank vs industry peers · Fliar Intelligence Index 40/100 | $11M | 17 mo ago | 30 | 2014 | Rutger Van Raalten Co-Founder & CEO | WordPressMySQLPHP+19 | 156 patents Carbon-based anode and conductive additive technologies for high‑performance Li/Na batteries | 1 partnership |
| 7 | Morphotonics Manufacturer of nanoimprint lithography equipment, materials, and related process solutions 32Talent top 28%Product top 30%Funding top 38%Moat top 45% All 10 signals ▾Talenttop 28% Producttop 30% Fundingtop 38% Moattop 45% Techbottom 44% Innovationbottom 41% Globalbottom 40% Marketbottom 34% Patentsbottom 34% Newsbottom 18% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated Product: 6 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 32/100 | $10M | 23 mo ago | 34 | 2014 | Rob Erven Co-Founder | WordPressMySQLPHP+16 | 5 patents Flexible photolithography stamps offering tunable high-dimensional stability | 5 job openings · 1 launch |
| 8 | Malvern Panalytical R&D company focused on manufacturing of medical instruments for multiple industries | $7M | 58 mo ago | 1,771 | 2017 | — | Apple iCloud MailMicrosoft 365YouTube+22 | 136 patents Advanced X‑ray fluorescence, diffraction, and analysis instrumentation for material characterization | — |
| 9 | Applied Nanolayers Provider of low defect density monolayer-graphene and hexagonal boron nitride | $6M | 70 mo ago | 21 | 2012 | — | — | 10 patents Equipment and methods for transferring, cleaning, and heating substrates in 2D material processing | — |
| 10 | MyLife Technologies Developer of a nanotech-based drug delivery system | $4M | 56 mo ago | 12 | 2012 | — | — | — | — |
| 11 | Delmic B.V. Provider of light and electron microscopy solutions for life sciences and materials science | $4M | 40 mo ago | 50 | 2011 | Sander Hoedt CEO | HubSpot CMS HubRequireJSLazySizes+19 | 88 patents Focused ion beam micromachining and multi-beam charged‑particle sample inspection systems | — |
| 12 | Kriya Materials Develops nanocoatings for energy efficiency purposes | $4M | 99 mo ago | 13 | 2006 | Roel Huis CEO | — | 8 patents Antistatic polymer coating compositions for cured films and laminate applications | — |
| 13 | Eurekite Developer of flexible ceramic material | $4M | 66 mo ago | — | 2015 | — | — | — | — |
| 14 | OncoLize Developer of injectable drug depots to treat tumors | $2M | 39 mo ago | 5 | 2017 | Mike De Leeuw Chief Executive Officer & Founder | — | — | — |
| 15 | LipoCoat Developer of hydrophilic bioinspired coatings for medical devices | $2M | 70 mo ago | 18 | 2016 | Pascal Jonkheijm Co-Founder | — | 11 patents Lipid-based coating technologies for medical devices and drug delivery systems | — |
| 16 | RGS Development Thermoelectric heat panels to convert waste heat into electricity | $1M | 116 mo ago | 12 | 2000 | Axel Schonecker Founder & CTO | — | — | — |
| 17 | NX Filtration Provider of advanced hollow fiber membrane module for nanofiltration | $913K | 48 mo ago | 126 | 2012 | Erik Roesink Founder | WordPressMySQLSalesforce+21 | 16 patents Membrane filtration hardware and porous film manufacturing for water treatment systems | 2 partnerships |
| 18 | 20Med Therapeutics Develops RNA-based therapeutics and vaccines for drug delivery | $736K | 38 mo ago | 13 | 2011 | Michiel Lodder CEO | — | 15 patents Patents concentrated in chemistry & materials | — |
| 19 | Splendo Developer of mobile applications, IoT solutions, and time series models | $423K | 68 mo ago | — | 2001 | Luc Demarteau Founder & CEO | — | — | — |
| 20 | Aquamarijn Nano-engineering based filtration cell detection and nanopatterning | $269K | 115 mo ago | — | 1994 | Cees Van Rijn Founder & CEO | — | — | — |
Top 12 Nanotechnology companies in Netherlands
#1
Series A · Amsterdam, North Holland · founded 2014 · 30 employees$10.7Mraised▾
Manufacturer of nanosized carbon structures. It provides users with carbon material composed of nano-sized carbon filaments which are chemically connected to form a three-dimensional micron-sized network. It also combines the properties and delivers high performance and greater sustainability.
- Feb 2025Series A$5.2M
- Feb 2025Grant (prize money)$2.6M
- Dec 2024Series A$4.2M
- Feb 2024Series A$10.7M
#2
Series C · Rotterdam, South Holland · founded 2016 · 152 employees$168.8Mraised▾
Developer of electron microscopes for 3D metrology. It provides users with a high throughput atomic force microscopy system for atom-scale resolution 3D metrology. It also caters to semiconductors manufacturing industries to measure nanoscale products, and understand the functionality of microchips and on-device non-destructive measurements.
- Jul 2024Series C$147.5M
- May 2023Series B—
- Jun 2021Series B$21.3M
- Sep 2017Seed—
#3
Series B · Veldhoven, North Brabant · founded 2014 · 34 employees$10Mraised▾
Manufacturer of nanoimprint lithography equipment, materials, and related process solutions. The company provides hardware and proprietary materials for nanoscale feature replication on large surfaces. It offers solutions for high-volume production, supporting consumer electronics manufacturing. The company’s platform enables integration of optical features for displays and smart glasses.
- Sep 2024Series B$10M
- Jun 2023Grant (prize money)$2.7M
- Jan 2020Grant (prize money)$895.9K
- Jul 2019Seed—
#4
Series A · Delft, South Holland · founded 2014 · 26 employees$26.8Mraised▾
Provider of nanopowder manufacturing services. It is specialised in the development of nanoparticle generators. These are devices that produce particles with diameters in the nanoparticle range. The new equipment uses spark ablation technology. The company claims that it can be used to speedily generate various nanoparticles at industrial volume. It can be used for applications such as printed electronics, catalysis, nanotoxicity research, and sensors.
- Aug 2024Series A$7.1M
- Jul 2023Grant (prize money)$3.8M
- Jul 2023Series A$15.8M
- Sep 2021Seed—
#5
Series A · Delft, South Holland · founded 2014 · 24 employees$11.6Mraised▾
Provider of sustainable powders for batteries. It develops powders for batteries, fuel cells, electrolysers and more. It uses atomic layer decomposition solution for layering process.
- May 2024Series A$3.2M
- Oct 2021Series A$11.6M
- Oct 2020Seed—
- Jan 2020Grant (prize money)$405.3K
#6
Series A · Delft, South Holland · founded 2011 · 50 employees$4.3Mraised▾
Provider of light and electron microscopy solutions for life sciences and materials science. The company claims to have developed a platform for integrated fluorescence and electron microscopy and a cathodoluminescence detection system. It also provides an integrated fluorescence and scanning electron microscope.
- Apr 2023Series A$4.3M
- Nov 2019Grant (prize money)$120K
- Sep 2019Grant (prize money)$2.4M
- Jan 2019Grant (prize money)$14.3K
#7
Series B · Maastricht, Limburg · founded 2011 · 6 employees$21.2Mraised▾
Cristal Therapeutics (formerly Cristal Delivery) is developing the nanomedicines based on its proprietary CriPec platform for cancer and inflammation. The technology platform consists of tunable polymers, biodegradable drug linkers, and targeting ligands that enable the design and development of targeted nanomedicines. Its lead product is CriPec docetaxel for the treatment of solid tumors is in phase 2 trials. The company also has 3 drugs i.e CPC634, CPC205 and CPC879 in proof of concept trials for inflammation and tumors.
- Oct 2020Grant (prize money)$151.3K
- Nov 2017Grant (prize money)$3M
- Aug 2017Grant (prize money)$3M
- Jan 2017Series B$13.7M
#8
Funding Raised · Almelo, Overijssel · founded 2017 · 1771 employees$7.5Mraised▾
R&D company focused on manufacturing of medical instruments for multiple industries
- Sep 2021Grant (prize money)$107.3K
- Jul 2021Grant (prize money)$140.8K
- May 2020Grant (prize money)$937.4K
- Oct 2018Grant (prize money)$18.2K
#9
Seed · Maastricht, Limburg · founded 2017 · 5 employees$1.7Mraised▾
Developer of injectable drug depots to treat tumors. Through oral medication or intravenous injections, the company employs thin needles or catheters to localize the small drug depot inside the solid tumor. It creates a variety of depots carrying various Chemo-drugs for the brain, as well as pancreatic, prostate, and urinary tract cancers.
- Apr 2023Seed$1.7M
#10
Series A · South Holland · founded 2011 · 13 employees$735.8Kraised▾
Develops RNA-based therapeutics and vaccines for drug delivery. Its non-viral delivery platform is based on bioresponsive polymers designed for the intracellular delivery of oligonucleotides. The 20Med Nanoparticles are applicable for the delivery of oligonucleotide-based therapeutics. Its nanogel drug delivery platform provides protection of fragile payloads during administration and circulation but allows for a rapid bioresponsive release of that payload as the particles enter the cytosol. The bioresponsive polymeric nanoparticles can be loaded with oligonucleotides ranging from large plasmid DNAs (>12Kb) to small antisense oligos.
- May 2023Series A—
- Sep 2020Grant (prize money)$316.7K
- Nov 2017Seed—
- Jan 2017Grant (prize money)$419.1K
#11
Series A · Leiden, South Holland · founded 2012 · 12 employees$4.3Mraised▾
Developer of a nanotech-based drug delivery system. The company is developing a drug delivery system based on a npMNA platform technology for dermal drug delivery of vaccines, peptides, and small molecules. This nanoporous MicroNeedle Arrays technology involves the storage of drugs into the nanopores, the npMNA is then incorporated into a patch and the system is then used for drug delivery.
- Nov 2021Series A$4M
- Dec 2019Grant (prize money)—
- Nov 2018Seed$339.3K
#12
Acquired · The Hague, South Holland · founded 2012 · 21 employees$5.7Mraised▾
Provider of low defect density monolayer graphene and hexagonal boron nitride. It leverages chemical vapour deposition technology that enables integration with existing substrates such as Si, GaAs, and InP. Its products are used in multiple applications including semiconductor devices, EUV pellicles, membranes, sensors, photonics, spintronics, and THz devices.
- Oct 2020Grant (prize money)$311.9K
- Oct 2019Grant (prize money)$2.7M
- Oct 2019Grant (prize money)$2.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Nanotechnology coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Nanomaterials is moving in the Netherlands
A read on the academic research around Nanomaterials — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 543 Netherlands-affiliated papers.
- Institute of Physics130
- Eindhoven University of Technology76
- Delft University of Technology75
- University of Groningen44
- Utrecht University33
- Nanoparticle4→59
- Quantum dot3→22
- Catalysis1→16
- Nanotechnology2→16
- Plasmon2→15
- Nanoparticle5→51
- Catalysis2→14
- Nanocomposite1→8
- Nanotechnology4→11
- Photocatalysis1→7
- Nanoparticle7
- Nanotechnology6
- Quantum dot4
- Toxicity3
- Nanotoxicology3
Where nanomaterials is researched across Netherlands
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.